15/10/02说明:此前论坛服务器频繁出错,现已更换服务器。今后论坛继续数据库备份,不备份上传附件。

肝胆相照论坛

 

 

肝胆相照论坛 论坛 学术讨论& HBV English 缺乏肝细胞STING的有利于乙肝病毒感染
查看: 1697|回复: 1
go

缺乏肝细胞STING的有利于乙肝病毒感染 [复制链接]

Rank: 8Rank: 8

现金
62111 元 
精华
26 
帖子
30441 
注册时间
2009-10-5 
最后登录
2022-12-28 

才高八斗

1
发表于 2016-7-27 14:29 |只看该作者 |倒序浏览 |打印
A lack of hepatocyte STING favours HBV infection
HBV selectively infects hepatocytes
and can cause chronic hepatitis
that might lead to hepatocellular
carcinoma. Knowledge of how chronic
HBV infections are established was
previously limited. Research published
in Hepatology now provides insight into
this process, showing that hepatocytes
lack the ability to recognize foreign HBV
DNA, thereby hampering the innate
immune response.
The recognition of foreign DNA
(such as some viruses) is performed by
intracellular DNA-sensing proteins,
which then activate the stimulator of
interferon genes (STING) — ultimately
leading to the expression of interferons
that contribute to the immune response
towards viral infections. However,
how HBV has adapted to specifically
replicate in hepatocytes and which
immune mechanisms might be involved
in controlling the virus was not understood.
“[My] laboratory has experience in
innate immunology to DNA viruses,
mainly with a focus on herpesviruses,”
explains senior author Søren Paludan. As
STING had previously shown important
roles in controlling herpes and other
DNA viruses, and given that an earlier
immune response to HBV infection
might lead to a more effective clearance
of the virus by the host, the investigators
chose to examine the role of the STING
pathway in controlling HBV infections.
Using an in vivo mouse model of
HBV infection, in which the virus was
encoded in an adenoviral vector,
the most important finding was that
hepatocytes do not express STING and
do not induce antiviral interferons in
response to foreign DNA. However, when
STING was specifically introduced into
hepatocytes, DNA-sensing was enabled
and led to restricted HBV replication.
Furthermore, the researchers found
that primary human hepatocytes also
lacked detectable levels of STING and
had reduced responsiveness to foreign
DNA, validating the results from the
mouse model.
“It has been reported that hepatocytes
do not respond with strong interferon
responses to HBV infection. We now
provide the mechanism underlying
the phenomenon,” concludes Paludan,
which might also explain why HBV has
adapted to replicate in hepatocytes.
In terms of future work, he believes
two options are worthwhile: “One is
to understand why hepatocytes have
evolved to not respond immunologically
to foreign DNA. Another is to explore
how other cell types in the liver (resident
and infiltrating) sense HBV, and how the
virus seeks to evade these responses.”
Iain Dickson

ORIGINAL ARTICLE Thomsen, M. K. et al. Lack
of immunological DNA sensing in hepatocytes
facilitates hepatitis B virus infection. Hepatology
http://dx.doi.org/10.1002/hep.28685 (2016)

Rank: 8Rank: 8

现金
62111 元 
精华
26 
帖子
30441 
注册时间
2009-10-5 
最后登录
2022-12-28 

才高八斗

2
发表于 2016-7-27 14:30 |只看该作者
缺乏肝细胞STING的有利于乙肝病毒感染
HBV感染选择性肝
并且可引起慢性肝炎
可能导致肝癌
癌。知识如何慢性
HBV感染是建立
以前的限制。相关研究发表
在肝病现在提供洞察
这个过程中,显示​​出肝细胞
缺乏承认外国乙肝病毒的能力
DNA,从而阻碍了先天
免疫反应。
外源DNA的识别
(如某些病毒)被执行
细胞内的DNA感应蛋白,
然后激活的刺激
干扰素基因(STING) - 最终
导致干扰素的表达
有助于免疫反应
向病毒感染。然而,
乙肝病毒是如何适应具体
复制在肝细胞和其
免疫机制可能涉及
在控制病毒不被理解。
“[我]实验室拥有经验
先天免疫的DNA病毒,
主要侧重于疱疹病毒“
解释资深作者索伦Paludan。如
STING此前曾表示重要
在控制疱疹等角色
DNA病毒,鉴于先前的
HBV感染的免疫反应
可能导致更有效地清除
该病毒由主机,调查者
选择检查STING的作用
通路控制乙肝病毒感染。
使用的体内小鼠模型
HBV感染,其中所述病毒为
在腺病毒载体编码,
最重要的发现是,
肝细胞不表达和STING
不诱导抗病毒干扰素
应对国外的DNA。然而,当
STING是专门引入
肝细胞,DNA的感测启用
并导致限制HBV的复制。
此外,研究人员发现
该原代人肝细胞也
缺乏STING的检测水平和
减少了反应国外
DNA,确认从结果
小鼠模型。
“它已经报道了肝细胞
不具有很强的干扰素响应
反应HBV感染。我们现在
提供底层机制
的现象,“总结Paludan,
这也可以解释为什么有HBV
适于在肝细胞中复制。
在今后的工作而言,他认为
两个选项是值得的:“一个是
理解为什么有肝细胞
发展到不回应免疫
外源DNA。另一种是探索
如何其他细胞类型在肝脏(驻留
和渗透的)意义HBV,以及如何
病毒试图逃避这些反应。“
伊恩·迪克森

论着汤姆森,M K等。缺乏
在肝细胞免疫DNA传感
有利于乙肝病毒感染。肝病
http://dx.doi.org/10.1002/hep.28685(2016)
‹ 上一主题|下一主题
你需要登录后才可以回帖 登录 | 注册

肝胆相照论坛

GMT+8, 2024-5-19 23:32 , Processed in 0.013161 second(s), 11 queries , Gzip On.

Powered by Discuz! X1.5

© 2001-2010 Comsenz Inc.